Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. Aging Knowl. Environ., 8 March 2006
Vol. 2006, Issue 6, p. re1
[DOI: 10.1126/sageke.2006.6.re1]

The Development of Amyloid beta Protein Deposits in the Aged Brain

Dietmar R. Thal, Estibaliz Capetillo-Zarate, Kelly Del Tredici, and Heiko Braak

The authors are at the Department of Neuropathology, University of Bonn, D-53105 Bonn, Germany (D.R.T. and E.C.-Z.) and at the Institute for Clinical Neuroanatomy, J. W. Goethe University, D-60590 Frankfurt am Main, Germany (K.D.T. and H.B.). E-mail: Dietmar.Thal{at}uni-bonn.de (D.R.T.)

http://sageke.sciencemag.org/cgi/content/full/2006/6/re1

Key Words: senile plaques • amyloid beta protein • Alzheimer's disease • tau

Abstract: The deposition of amyloid beta protein (Abeta) in the human brain and the generation of neurofibrillary tangles are the histopathological hallmarks of Alzheimer's disease. Accumulation of Abeta takes place in senile plaques and in cerebrovascular deposits as a result of an imbalance between Abeta production and clearance. This Review describes the different types of Abeta deposits, which can be distinguished by their morphology and by the hierarchical involvement of distinct areas of the brain in Abeta deposition. The role of intracellular Abeta in Abeta deposition and the mechanism of Abeta toxicity are also discussed.

Citation: D. R. Thal, E. Capetillo-Zarate, K. Del Tredici, H. Braak, The Development of Amyloid beta Protein Deposits in the Aged Brain. Sci. Aging Knowl. Environ. 2006 (6), re1 (2006).

Read the Full Text




THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
"New Old Pathologies": AD, PART, and Cerebral Age-Related TDP-43 With Sclerosis (CARTS).
P. T. Nelson, J. Q. Trojanowski, E. L. Abner, O. M. Al-Janabi, G. A. Jicha, F. A. Schmitt, C. D. Smith, D. W. Fardo, W.-X. Wang, R. J. Kryscio, et al. (2016)
J Neuropathol Exp Neurol 75, 482-498
   Abstract »    Full Text »    PDF »
Perforant path synaptic loss correlates with cognitive impairment and Alzheimer's disease in the oldest-old.
J. L. Robinson, L. Molina-Porcel, M. M. Corrada, K. Raible, E. B. Lee, V. M.- Y. Lee, C. H. Kawas, and J. Q. Trojanowski (2014)
Brain 137, 2578-2587
   Abstract »    Full Text »    PDF »
Mild Cognitive Impairment and Asymptomatic Alzheimer Disease Subjects: Equivalent {beta}-Amyloid and Tau Loads With Divergent Cognitive Outcomes.
D. Iacono, S. M. Resnick, R. O'Brien, A. B. Zonderman, Y. An, O. Pletnikova, G. Rudow, B. Crain, and J. C. Troncoso (2014)
J Neuropathol Exp Neurol 73, 295-304
   Abstract »    Full Text »    PDF »
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature.
P. T. Nelson, I. Alafuzoff, E. H. Bigio, C. Bouras, H. Braak, N. J. Cairns, R. J. Castellani, B. J. Crain, P. Davies, K. D. Tredici, et al. (2012)
J Neuropathol Exp Neurol 71, 362-381
   Abstract »    Full Text »    PDF »
Telomere shortening reduces Alzheimer's disease amyloid pathology in mice.
H. Rolyan, A. Scheffold, A. Heinrich, Y. Begus-Nahrmann, B. H. Langkopf, S. M. Holter, D. M. Vogt-Weisenhorn, B. Liss, W. Wurst, D. C. Lie, et al. (2011)
Brain 134, 2044-2056
   Abstract »    Full Text »    PDF »
Induction of cerebral {beta}-amyloidosis: Intracerebral versus systemic A{beta} inoculation.
Y. S. Eisele, T. Bolmont, M. Heikenwalder, F. Langer, L. H. Jacobson, Z.-X. Yan, K. Roth, A. Aguzzi, M. Staufenbiel, L. C. Walker, et al. (2009)
PNAS 106, 12926-12931
   Abstract »    Full Text »    PDF »



To Advertise     Find Products


Science of Aging Knowledge Environment. ISSN 1539-6150